{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:21:28Z","timestamp":1782955288085,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2021,6,8]]},"abstract":"<jats:sec>\n<jats:title>Abstract::<\/jats:title>\n<jats:p>Insulin is a lifesaving drug for patients with type 1 diabetes mellitus. Many type 2 diabetes\nmellitus patients will eventually require insulin. The rapid-acting and long-acting insulin analogues\n(RAIAs and LAIAs) have a pharmacological profile that closely mimics normal human physiology\nwhen compared to Neutral Protamine Hagedorn (NPH) insulin and regular human insulin,\nrespectively. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) were found to have a proven\ncardiovascular safety. They are preferred over insulin in many recent guidelines. Fixed-ratio combinations\nof GLP-1RAs and insulin are also recommended when either of these molecules fail to\nachieve glycaemic control. Despite decades of experience in using insulin, there is a debate among\nthe scientific community over the safety of exogenous insulin, especially regarding their cardiovascular\nsafety and the risk of cancer. There is also an ongoing debate regarding the safety, even\nthough two long-acting insulin analogues (glargine and degludec) have proven their cardiovascular\nnon-inferiority. Drugs with proven safety are often preferred in patients with pre-existing cardiovascular\ndisease or at high risk of cardiovascular disease. In this review we will critically analyse efficacy\nand safety issues related to insulin molecules to help in clinical decision making.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886315999201105153458","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T05:42:47Z","timestamp":1604641367000},"page":"217-232","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Cardiovascular Safety of Insulins"],"prefix":"10.2174","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-5525","authenticated-orcid":true,"given":"Cornelius James","family":"Fernandez","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Pilgrim Hospital, Boston, PE21 9QS, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-0651","authenticated-orcid":true,"given":"Chandni","family":"Radhakrishnan","sequence":"additional","affiliation":[{"name":"Professor of Medicine and Head of Department of Emergency Medicine, Govternment Medical College Kozhikode, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/187633","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187633\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/187633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T07:24:03Z","timestamp":1623655443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187633\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886315999201105153458","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}